Incidence, Risk Factors, and Outcomes of Cancer in Systemic Sclerosis.
Kathleen MorrisroeDylan HansenMolla HuqWendy StevensJoanne SahharGene-Siew NgianNava FerdowsiCatherine HillJanet RoddyJennifer WalkerSusanna ProudmanMandana NikpourPublished in: Arthritis care & research (2020)
SSc carries an increased risk of developing cancer, particularly lung cancer associated with ILD, and breast cancer and melanoma occurring close to SSc disease onset in association with RNAP antibodies. Compared to those patients without cancer, patients with SSc and cancer had higher mortality and an increased health care cost, with an annual excess per patient cost of $1,496 Australian (P < 0.001).
Keyphrases
- papillary thyroid
- systemic sclerosis
- risk factors
- squamous cell
- healthcare
- end stage renal disease
- lymph node metastasis
- chronic kidney disease
- peritoneal dialysis
- adipose tissue
- coronary artery disease
- metabolic syndrome
- ejection fraction
- cardiovascular disease
- insulin resistance
- skeletal muscle
- prognostic factors
- cardiovascular events
- social media